Open AccessSunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D3
Author(s) -
Chie Nishioka,
Takayuki Ikezoe,
Jinsong Yang,
Akihito Yokoyama
Publication year - 2009
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/leu.2009.152
Subject(s) - cd135 , sunitinib , tyrosine kinase inhibitor , cancer research , tyrosine kinase , chronic myelogenous leukemia , leukemia , medicine , receptor , pharmacology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom